Dong-A ST paying careful attention on the Chinese ABS due to the Korea-China FTA

Published: 2015-02-10 13:55:03

Updated: 2015-02-10 13:55:03

As the actual settlement of the Korea-China FTA (Free Trade Agreement) has been made last November, domestic pharmaceutical companies are actively exploring and responding to the impact.

In particular, Dong-A ST using natural resources from China has kept its eyes on the Chinese Nagoya Protocol that has not been enforced yet.

Since Dong-A ST need import natural resources from China for its cu...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.